H.R. 3281 118th Congress
Transparent PRICE Act
- Health
- Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
- Congress.gov ↗
Latest action, May 17, 2023: Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by the Yeas and Nays: 27 - 0 .
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
2 cosponsors
Sponsored by Rep. McMorris Rodgers, Cathy [R-WA-5] (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
2 D · 0 R
Referred to: House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
AMAC ACTION, INC.
SCHOENING STRATEGIES, LLC
7 reports
ASSOCIATION OF AMERICAN MEDICAL COLLEGES
RUBIN HEALTH POLICY CONSULTING, LLC
7 reports
7 reports
7 reports
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)
NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES
7 reports
7 reports
6 reports
CONTINENTAL AUTOMOTIVE SYSTEMS, INC.
CONTINENTAL TIRE THE AMERICAS, LLC
6 reports
THE METROHEALTH SYSTEM
ALSTON & BIRD LLP
5 reports
ADVOCATES FOR COMMUNITY HEALTH
TARPLIN, DOWNS & YOUNG, LLC
3 reports
All 25 of 52 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMAC ACTION, INC. | SCHOENING STRATEGIES, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| ASCENSION HEALTH ALLIANCE D/B/A ASCENSION | 7 | $3.5M | Q4 2023 | Q3 2024 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | RUBIN HEALTH POLICY CONSULTING, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| CALIFORNIA HOSPITAL ASSOCIATION | 7 | $2.7M | Q4 2023 | Q3 2024 | yes | |
| KAISER FOUNDATION HEALTH PLAN INC | 7 | $4.4M | Q4 2023 | Q3 2024 | yes | |
| NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.) | NATIONAL ASSOCIATION OF CHILDRENS HOSPITALS AND AFFILIATES | 7 | $11.8M | Q4 2023 | Q3 2024 | yes |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 7 | $2.5M | Q4 2023 | Q3 2024 | yes | |
| THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) | 7 | $13.5M | Q4 2023 | Q3 2024 | yes | |
| THE METROHEALTH SYSTEM | 7 | $940K | Q4 2023 | Q3 2024 | yes | |
| AMGEN INC | 6 | $18.1M | Q4 2023 | Q3 2024 | yes | |
| CONTINENTAL AUTOMOTIVE SYSTEMS, INC. | CONTINENTAL TIRE THE AMERICAS, LLC | 6 | $1.1M | Q1 2023 | Q2 2024 | yes |
| HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA | 6 | $413K | Q4 2023 | Q3 2024 | yes | |
| THE METROHEALTH SYSTEM | ALSTON & BIRD LLP | 5 | $0 | Q4 2023 | Q2 2024 | yes |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 4 | $17.5M | Q4 2023 | Q1 2024 | yes | |
| ADVOCATES FOR COMMUNITY HEALTH | TARPLIN, DOWNS & YOUNG, LLC | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| ALNYLAM PHARMACEUTICALS | THE MCMANUS GROUP | 3 | $50K | Q4 2023 | Q3 2023 | yes |
| AMERICAN HOSPITAL ASSOCIATION | THE NICKLES GROUP, LLC | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) | 3 | $1.1M | Q4 2023 | Q3 2023 | yes | |
| CIGNA CORPORATION | INVARIANT LLC | 3 | $270K | Q4 2023 | Q1 2024 | yes |
| CLEVELAND CLINIC FOUNDATION | THE NICKLES GROUP, LLC | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| FLORIDA HOSPITAL ASSOCIATION | THE NICKLES GROUP, LLC | 3 | $0 | Q4 2023 | Q3 2023 | yes |
| GSK (FKA GLAXOSMITHKLINE INC.) | 3 | $3.4M | Q4 2023 | Q3 2023 | yes | |
| OCHSNER CLINIC FOUNDATION | 3 | $550K | Q4 2023 | Q3 2023 | yes | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 3 | $19.1M | Q4 2023 | Q3 2023 | yes | |
| TRAUMA CENTER ASSOCIATION OF AMERICA | WASHINGTON STRATEGIC CONSULTING | 3 | $60K | Q4 2023 | Q3 2023 | yes |